FMOC-L-CYCLOPENTYLGLYCINE

CAS220497-61-0

FMOC-L-CYCLOPENTYLGLYCINE (CAS 220497-61-0, C22H23 N O4) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.

Chemical structure of FMOC-L-CYCLOPENTYLGLYCINE
C22H23 N O4 · 365.42 g/mol
CAS No.
220497-61-0
Formula
C22H23 N O4
Mol. weight
365.42 g/mol

Chemical Specifications

Identifiers

CAS number 220497-61-0
Product name FMOC-L-CYCLOPENTYLGLYCINE
Chinese name N-ALPHA-(9-芴甲氧羰基)-L-BETA-环戊基甘氨酸
Synonyms N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-L-CYCLOPENTYLGLYCINE
Chinese synonyms N-ALPHA-(9-芴甲氧羰基)-L-BETA-环戊基甘氨酸; FMOC-L-环戊; FMOC-L-环戊烷甘氨酸; (S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-2-环戊乙酸
Molecular formula C22H23 N O4
Molecular weight 365.42 g/mol

Packaging, Storage & Transport

Available pack sizes 5kg, 1kg, 500g, 100g, 50g, 10g

Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.

Frequently Asked Questions

What is the CAS number of FMOC-L-CYCLOPENTYLGLYCINE?

The CAS Registry Number of FMOC-L-CYCLOPENTYLGLYCINE is 220497-61-0. FMOC-L-CYCLOPENTYLGLYCINE is also known as N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-L-CYCLOPENTYLGLYCINE.

What is the molecular formula and molecular weight of FMOC-L-CYCLOPENTYLGLYCINE?

The molecular formula of FMOC-L-CYCLOPENTYLGLYCINE is C22H23 N O4, and its molecular weight is 365.42 g/mol.

How can I request a quotation for FMOC-L-CYCLOPENTYLGLYCINE?

Send an inquiry for FMOC-L-CYCLOPENTYLGLYCINE (CAS 220497-61-0) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.

Request a Quote for FMOC-L-CYCLOPENTYLGLYCINE

Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.

Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.